Optimer Pharmaceuticals (OPTR): Q4 EPS of $0.29 may not be comparable to consensus of $0.51....

|About: Optimer Pharmaceuticals,... (OPTR)|By:, SA News Editor
Optimer Pharmaceuticals (OPTR): Q4 EPS of $0.29 may not be comparable to consensus of $0.51. Revenue of $64.6M beats by $21M. Shares +0.9% AH. (PR)